Quick Answer
FATE THERAPEUTICS INC reported Research And Development Expense of $107.83 million for the year ending 2025.
- FATE THERAPEUTICS INC showed a decrease of -20.1% in Research And Development Expense from 2024 to 2025.
- This data is from FATE THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), FATE THERAPEUTICS INC's Research And Development Expense has grown by 993.8%.
- Historical annual values: Fiscal year 2025: $107.83 million | Fiscal year 2024: $135.00 million | Fiscal year 2023: $172.60 million | Fiscal year 2022: $320.45 million | Fiscal year 2021: $215.52 million | Fiscal year 2020: $125.62 million | Fiscal year 2019: $87.77 million | Fiscal year 2018: $56.02 million | Fiscal year 2017: $34.36 million | Fiscal year 2016: $26.45 million | Fiscal year 2015: $19.86 million | Fiscal year 2014: $16.44 million | Fiscal year 2013: $12.01 million | Fiscal year 2012: $12.00 million | Fiscal year 2011: $9.86 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: